Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.23.2
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Revenue:        
Product revenue, net $ 16,961 $ 18,235 $ 29,126 $ 39,031
Other revenue 211 56 259 2,556
Total revenue 17,172 18,291 29,385 41,587
Operating expenses        
Cost of goods sold - product revenue 7,767 7,633 14,216 15,836
Research and development 1,774 2,609 3,807 3,875
Selling, general and administrative 12,141 15,191 25,433 29,906
Loss on impairment of intangible assets 3,143   3,143  
Total operating expenses 24,825 25,433 46,599 49,617
Loss from operations (7,653) (7,142) (17,214) (8,030)
Other expense (income)        
Interest income (79) (4) (201) (7)
Interest expense 756 454 1,406 843
Foreign exchange transaction losses 33   80  
Total other expense (income) 710 450 1,285 836
Loss before income taxes (8,363) (7,592) (18,499) (8,866)
Income tax (benefit) expense   (64)   40
Net Loss $ (8,363) $ (7,528) $ (18,499) $ (8,906)
Net loss per common share:        
Basic $ (0.46) $ (0.43) $ (1.03) $ (0.51)
Diluted $ (0.46) $ (0.43) $ (1.03) $ (0.51)
Weighted average number of common shares:        
Basic 18,005,055 17,455,894 17,906,671 17,386,538
Diluted 18,005,055 17,455,894 17,906,671 17,386,538